Please use this identifier to cite or link to this item:
|Title:||Consequences, Opportunities and Challenges of Modern Biotechnology for Europe|
|Authors:||BOCK ANNE-KATRIN; PAPATRYFON ILIAS; ZIKA Eleni; WOLF OLIVER; GOMEZ BARBERO MANUEL; STEIN Alexander Jivraj|
|Other Identifiers:||EUR 22728 EN|
|Type:||JRC Reference Reports|
|Abstract:||Modern biotechnology products and processes are an integral part of the EU economy, mainly in manufacturing, including pharmaceuticals, agro-food and healthcare. While some products are not recognizable to the broader public (e.g. the use of genetic markers in livestock breeding), others are used on a daily basis (detergents with enzymes, recombinant insulin) or have become subject of public discussion (e.g. genetically modified crops). Modern bioetchnology contributes significantly to the achievement of major EU polciy objectives.|
|JRC Institute:||Growth and Innovation|
Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.